X0706 D LIVE 0001378624 Cellular Biomedicine Group, Inc. 530 UNIVERSITY AVENUE, #17 PALO ALTO CA CALIFORNIA 94301 (480) 966-2020 DELAWARE EastBridge Investment Group Corp Corporation true 2013 Andrew Chan 530 University Avenue, #17 Palo Alto CA CALIFORNIA 94301 Executive Officer Wen Tao (Steve) Liu 530 University Avenue, #17 Palo Alto CA CALIFORNIA 94301 Executive Officer Wei (William) Cao 530 University Avenue, #17 Palo Alto CA CALIFORNIA 94301 Executive Officer Keith Wong 530 University Avenue, #17 Palo Alto CA CALIFORNIA 94301 Director Norman Klein 530 University Avenue, #17 Palo Alto CA CALIFORNIA 94301 Director Tony Liu 530 University Avenue, #17 Palo Alto CA CALIFORNIA 94301 Director Jainping Dai 530 University Avenue, #17 Palo Alto CA CALIFORNIA 94301 Director Other Health Care Decline to Disclose 06 false 2013-02-07 false true true Merger by and among the issuer (formerly EastBridge Investment Group Corp), CBMG Acquisition Limited (BVI) (Merger Sub) and Cellular Biomedicine Group Ltd. (BVI) (CBMG BVI), whereby Merger Sub merged with and into CBMG BVI, with CBMG BVI as the survivor 0 Indefinite 0 Indefinite Upon closing of the Merger CBMG BVI shareholders were issued 3,638,932 shares of common stock (CS) of EastBridge. Each of CBMG BVI?s shares was converted into right to receive 0.020019 share of EastBridge CS. At exchange no value per share was determined true 0 0 0 0 0 false Cellular Biomedicine Group, Inc. /s/ Andrew Chan Andrew Chan Chief Financial Officer 2013-06-25